Glycemia and prognosis of patients with chronic heart failure-Subanalysis of the Long-term Prospective Randomized Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients (REMADHE) trial

American Heart Journal

Volumn 159, Issue 1, 2010, Pages 90-97

  Issa, Victor S ^a   Amaral, Alexandre F ^a   Cruz, Fátima D ^a   Ayub Ferreira, Silvia M ^a   Guimarães, Guilherme V ^a   Chizzola, Paulo R ^a   Souza, Germano E C ^a   Bocchi, Edimar A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SPIRONOLACTONE; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATION; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; AGE FACTORS; BLOOD GLUCOSE; CAUSE OF DEATH; CHRONIC DISEASE; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMANS; HYPERGLYCEMIA; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; OUTPATIENTS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 71849085404     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.10.027     Document Type: Article

References (27)

1. Thrainsdottir I.S., Aspelund T., Thorgeirsson G., et al. The association between glucose abnormalities and heart failure in the population-based Rykjaviik study. Diabetes Cares 28 (2005) 612-616
2. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 (2000) 1628-1637
3. He J., Ogden L.G., Bazzano L.A., et al. Risk factors for congestive heart failure in US men and women: NHANES-I epidemiologic follow-up study. Arch Intern Med 161 (2001) 996-1002
4. Kannel W.B., Hjortland M., and Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34 (1974) 29-34
5. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycemia with macrovascular and microvascular complications of type-2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
6. Amato L., Paolisso G., Cacciatore F., et al. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 23 (1997) 213-218
7. Yusuf S., Ostergren J.B., Gerstein H.C., et al. Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation 112 (2005) 48-53
8. MacDonald M.R., Petrie M.C., Varyani F., et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure. Eur Heart J 29 (2008) 1377-1385
9. Domanski M., Krause-Steinrauf H., Deedwania P., et al. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST Trial. J Am Coll Cardiol 42 (2003) 914-922
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853
11. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
12. Eshaghian S., Horwich T.B., and Fonarow G.C. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J 151 (2006) 91
13. Kalantar-Zadeh K., Block G., Horwich T.B., et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004) 1439-1444
14. Bocchi E.A., Cruz F.D., Guimarães G.V., et al. Long-term prospective, randomized, controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients: the REMADHE Trial. Circ Heart Fail 1 (2008) 115-124
15. American Diabetes Association. Clinical practice recommendations. Diabetes Care 30 (2007) S42-S47
16. Rydén L., Standl E., Bartnik M., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. the Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 28 (2007) 88-136
17. Held C., Gerstein H.C., Yussuf S., et al. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 115 (2007) 1371-1375
18. Marantz P.R., Tobin J.N., Wassertheil-Smaller S., et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 77 (1988) 607-612
19. Henry W.I., Gardin J.M., and Ware J.H. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 62 (1980) 1054-1061
20. De Groote P., Lamblin N., Mouquet F., et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 25 (2004) 656-662
21. Ingelsson E., Sundström J., Arnlöv J., et al. Insulin resistance and risk of congestive heart failure. JAMA 294 (2005) 334-341
22. Suskin N., McKelvie R.S., Burns R.J., et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21 (2000) 1368-1375
23. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 (2009) 129-139
24. Aguilar D., Bozkurt B., Ramasubbu K., et al. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol 54 (2009) 422-428
25. Chess D.J., and Stanley W.C. Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc Res 79 (2008) 269-278
26. Scorrano L., Penzo D., Petronilli V., et al. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signaling. J Biol Chem 276 (2001) 12035-12040
27. Huss J.M., and Kelly D.P. Nuclear receptor signaling and cardiac energetics. Circ Res 95 (2004) 568-578